News

As the Wisconsin Opioid Overdose Response Center readies for launch, Senator Tammy Baldwin visits to witness the center’s early progress.

With an influx of federal aid, two School of Pharmacy professors — Jay Ford and Cody Wenthur — will empower Wisconsin pharmacies with new tools to prevent opioid deaths.

Listen to Associate Professor Cody Wenthur speak about the early stages of clinical trials using psilocybin and ketamine as treatments for challenging mental health conditions, as well as how the field is changing and growing.

See the people, processes, and equipment behind Assistant Professor Cody Wenthur’s exploration into psychoactive substances.

School of Pharmacy Assistant Professor Cody Wenthur and his team are shedding new light on the role of stress in psychedelic drug treatment for mental health disorders.

Assistant Professor Cody Wenthur has been selected for one of UW–Madison’s highest faculty honors.

Watch as Associate Professor Lucas Richert, of the Social and Administrative Sciences Division, and Professor Paul Hutson and Assistant Professor Cody Wenthur, both of the Pharmacy Practice and Translational Research Division, discuss where psychedelic research is today, what projects are underway here at UW–Madison, and how the role of pharmacists factors in. 

The two first-of-their-kind Paths of Distinction in psychiatric pharmacy and applied drug development give UW–Madison student pharmacists a competitive edge.

As psychoactive substances gain therapeutic evidence, Assistant Professor Cody Wenthur aims to reverse underrepresentation of minorities in clinical studies. 

Housed at the School of Pharmacy, the Transdisciplinary Center for Research in Psychoactive Substances leverages clinical and multidisciplinary expertise in emerging field of psychedelic-assisted therapy.

In response to a resurgence in research and a need for a highly trained workforce, the School of Pharmacy introduces a new MS in Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation — the only master’s program of its kind in the U.S.

A new study led by School of Pharmacy researchers seeks to separate the psychedelic experience from the drugs’ therapeutic effects.

By Eric Hamilton This article originally appeared on UW–Madison’s news page. University of Wisconsin–Madison scientists have discovered that a majority of people they tested who were taking opioid painkillers for chronic back pain produced antibodies against the drugs that may contribute to some of the negative side effects of long-term opioid use. The findings add to […]

With NIH BRAINS award, Assistant Professor Cody Wenthur is using a vaccine approach to develop safer and more effective antidepressants from ketamine.

In the first in a three-part series exploring how School of Pharmacy researchers are curbing the opioid epidemic, faculty are building a toolkit for pharmacists to get involved with opioid use disorder treatment, and paving the way for an opioid misuse vaccine.

Three new hires and two new appointments strengthen the School’s Pharmacy Practice and Pharmaceutical Sciences Divisions.